Fourth dose approved for immunocompromised individuals

Fourth dose approved for immunocompromised individuals

Greece’s National Vaccination Committee approved on Tuesday the administration of a fourth dose of a coronavirus vaccine to immunocompromised people.

The experts decided that this group will be able to get the fourth jab 3-6 months after the third.

The decision concerns patients with haematological and oncological illnesses who under treatment, people receiving immunosuppressive drugs, transplant recipients and patients with rheumatic diseases or renal failure.

Subscribe to our Newsletters

Enter your information below to receive our weekly newsletters with the latest insights, opinion pieces and current events straight to your inbox.

By signing up you are agreeing to our Terms of Service and Privacy Policy.